High depressive symptoms linked to increased e-cigarette use among Australian teens

A study on vaping behavior among Australian high school students has found those who reported severe depressive symptoms were over twice as likely to have tried e-cigarettes, compared to those reporting no depressive symptoms.

Breast Cancer Drugs May Weaken Effects of Weight-Loss Drugs

CHICAGO — Anti-obesity medications may not work quite as well in women taking certain breast cancer drugs, a researcher reported here. Among 99 breast cancer

June 19, 2023

Deep Brain Stimulation Revives Cognitive Function After Traumatic Brain Injury

Deep brain stimulation (DBS) in the central lateral nucleus of the thalamus led to cognitive improvements in people with long-term deficits due to traumatic brain

December 5, 2023

Eli Lilly releases single-dose vials of Zepbound at half the price of other obesity meds

Eli Lilly will begin selling single-dose vials of its drug tirzepatide, marketed as Zepbound for weight loss, and price them at least 50% lower than

August 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.